[
  {
    "article_id": 82,
    "article_title": "Developmental Delay",
    "sections": [
      {
        "title": "Assessment and Management",
        "content": "**Initial Assessment**\n\nWhen global developmental delay is suspected, obtain a detailed developmental history covering all domains: gross motor, fine motor, speech and language (receptive and expressive), cognition, social-personal development, and activities of daily living.\n\nAdminister age-appropriate, standardised, norm-referenced developmental tests to quantify delay across domains. Calculate the developmental quotient for each domain (developmental age ÷ chronological age × 100). A developmental quotient below 70% indicates significant delay; between 70–85% indicates mild or borderline delay.\n\n**Investigation**\n\nThe presence of global developmental delay should always prompt investigation into possible underlying causes. Genetic testing guidelines should be considered as part of the diagnostic workup.\n\n**Referral for Early Intervention**\n\nRefer every child with developmental concerns to:\n- Local early intervention programme or agency (ages 0–3 years)\n- Public school programme (ages ≥3 years)\n- Local therapy providers as appropriate\n\nThese services are entitled under the Individuals with Disabilities Education Act and should be accessed from as early as birth for known or high-risk conditions through age 21 years.\n\n**Ongoing Management**\n\nAs the child grows older and the clinical picture becomes clearer, transition from the umbrella term 'global developmental delay' to more specific descriptions of individual difficulties such as [[114|learning disability]], motor disorder, or communication difficulty. This allows for more targeted intervention and clearer prognostic information."
      }
    ]
  },
  {
    "article_id": 83,
    "article_title": "Pediatric Emergency Medicine",
    "sections": [
      {
        "title": "Clinical Approach",
        "content": "The reference passages provided focus on the definition and scope of Pediatric Emergency Medicine as a specialty but do not contain specific bedside management protocols, drug dosages, or procedural guidance. For detailed clinical management information including specific interventions, medications, and dosing regimens, consultation of the full textbook chapters and clinical guidelines is recommended."
      }
    ]
  },
  {
    "article_id": 84,
    "article_title": "Normal Child Development",
    "sections": [
      {
        "title": "Developmental assessment and surveillance",
        "content": "**Routine surveillance approach:**\n\nInformal and formal developmental surveillance should be performed at regular intervals. For extremely low birth weight (ELBW) infants, referral to early intervention programs is particularly important, as routine screening tests are not sensitive enough to detect subtle neurodevelopmental abnormalities.\n\n**Key [[10|developmental milestones]] to assess:**\n\nBy 3 months adjusted age:\n- Coos or vocalizes other than crying\n- Visually tracks a moving toy from side to side\n- Attempts to reach for a rattle held above chest\n- Pushes up on arms\n- Lifts and holds head up\n\nBy 6 months adjusted age:\n- Sits with support\n- Holds head up\n- Arms flexed and held back\n- Sits without support by 6–9 months\n- Arms free to reach and grasp\n\n**Red flags for abnormal motor development:**\n\nAt 1½–3 months: unable to lift head or push up on arms; constantly fisted hand; stiff extended legs; stiff leg on one side; difficulty moving out of this position\n\nAt 3–6 months: rounded back; unable to lift head; floppy trunk; stiff, crossed legs; stiff arms with extended legs; poor use of arms for play\n\nAt 6–9 months: poor head control; difficulty getting arms forward; will not take weight on legs; stiff legs with pointed toes; difficulty pulling to stand\n\n**Management:**\nChildren with identified developmental delays or abnormal findings should be referred for formal developmental assessment and early intervention services as appropriate."
      }
    ]
  },
  {
    "article_id": 85,
    "article_title": "Pediatric Surgery",
    "sections": [
      {
        "title": "Management of Neonatal Surgical Emergencies",
        "content": "**Immediate actions upon presentation:**\n\n1. **Exposed viscera are protected** — Nonadherent dressings are applied and changed as needed to prevent contamination and drying\n2. **The bowel is decompressed** — A nasogastric tube is placed for decompression\n3. **Careful positioning** — Positioning is maintained to minimize volvulus and bowel ischemia risk\n4. **Monitoring is established** — Close clinical observation is implemented for signs of deterioration\n5. **Pediatric surgery is consulted immediately** — Specialist input is not delayed\n\n**Preoperative optimization:**\n\n- Metabolic abnormalities, particularly [[321|hypoglycemia]], are corrected\n- Access is established for parenteral nutrition, which is prepared\n- Chest radiography and echocardiography are obtained to assess for cardiopulmonary abnormalities\n- Physiological readiness for general anesthesia is assessed — the neonate may not be cleared for surgery if significant cardiopulmonary abnormalities are present\n\n**Key principle:** Operative intervention is delayed if necessary to optimize the neonate's medical condition and ensure physiological stability before surgical reduction and repair are attempted."
      },
      {
        "title": "Management of Blunt Pancreatic Trauma",
        "content": "**Assessment:**\n\n- Emergency ultrasound is performed for rapid evaluation in acute trauma\n- Advanced imaging (computed tomography) is obtained for injury classification and severity assessment\n\n**Management approach:**\n\n- Nonoperative management is favored in children with blunt pancreatic trauma when feasible\n- Close observation and imaging surveillance are implemented during the nonoperative period\n- Operative intervention is reserved for complications or failure of conservative management\n\n**Rationale:** Nonoperative management preserves pancreatic tissue and function while avoiding unnecessary surgery in the pediatric population."
      }
    ]
  },
  {
    "article_id": 86,
    "article_title": "Infant Of Diabetic Mother",
    "sections": [
      {
        "title": "Management at the Bedside",
        "content": "**Immediate actions at delivery:**\n- The infant is evaluated immediately for birth trauma and major malformations\n- Blood glucose and hematocrit are obtained in the nursery\n- A focused physical examination of heart, kidneys, lungs, and extremities is performed\n- Jitteriness, tremors, convulsions, apnea, weak cry, and poor sucking are watched for\n- Any signs of [[151|respiratory distress]] in the delivery room are addressed immediately\n\n**First 24 hours:**\n- Blood glucose is monitored closely throughout the first 24 hours\n- Early feeding is initiated to help prevent [[321|hypoglycemia]]\n- Hypoglycemia is screened for and [[151|respiratory distress]] is assessed\n- Signs of cardiac disease (cardiomegaly on chest X-ray, murmur, signs of heart failure) are watched for\n- Abdominal distension and meconium passage (small left colon syndrome) are checked for\n\n**First 48 hours:**\n- Observation for jaundice continues\n- Renal, cardiac, neurologic, and gastrointestinal abnormalities are assessed for\n- Jitteriness after 24 hours is monitored for (may indicate [[368|hypocalcemia]] or hypomagnesemia rather than [[321|hypoglycemia]])\n- Signs of [[151|respiratory distress]] from immature lungs are watched for\n\n**Note:** Hypoglycemia typically resolves within 1–2 days as pancreatic insulin secretion decreases. The passages provided do not specify glucose targets, monitoring intervals, or treatment protocols for hypoglycemia."
      }
    ]
  },
  {
    "article_id": 87,
    "article_title": "Pediatric Orthopedics",
    "sections": [
      {
        "title": "Clinical Assessment and Management",
        "content": "**Initial Evaluation**\n\nWhen a child presents with an orthopedic problem:\n\n1. **History**: Age of onset, whether congenital or acquired, and whether the condition is progressive or stable are determined\n2. **Physical examination**: Any deformities are measured and documented using standardized reference values for normal rotational and angular measurements\n3. **Functional assessment**: Pain, functional limitations, or gait abnormalities are evaluated for\n\n**Decision-Making**\n\n- **Reassurance and observation**: Many lower extremity rotational and angular variations resolve spontaneously during childhood growth and require only parental education and periodic follow-up\n- **Specialist referral**: Referral to a pediatric orthopedic surgeon is made when:\n  - Detailed evaluation beyond primary care scope is needed\n  - Deformity is progressive despite observation\n  - Significant functional impairment is present\n  - Surgical intervention may be indicated\n  - Diagnostic uncertainty exists\n\n**Follow-up**\n\nFor conditions managed conservatively, periodic reassessment is arranged to monitor for progression and ensure appropriate development. Baseline measurements are documented to allow comparison at subsequent visits."
      }
    ]
  },
  {
    "article_id": 88,
    "article_title": "Adolescent Depression",
    "sections": [
      {
        "title": "Assessment and Initial Management",
        "content": "**Screening and Identification**\n\nScreening for adolescent depression is performed routinely in primary care settings. Assessment explores the cardinal features: sadness, irritability, and loss of interest or pleasure in activities. Associated symptoms including changes in school performance, social withdrawal, sleep and appetite disturbance, and nonspecific physical complaints are evaluated for. Functional impairment across home, school, and peer relationships is assessed.\n\n**Risk Assessment**\n\nAll depressed adolescents require evaluation for suicide risk. Specific risk factors are identified: history of bullying (victim or perpetrator), substance use, coexisting psychiatric conditions, chaotic home environment, and recent humiliation or perceived failure. Any psychotic symptoms such as hallucinations or paranoid ideation are documented.\n\n**Treatment Considerations**\n\nManagement typically involves antidepressant medication, psychotherapy (including cognitive behaviour therapy, interpersonal therapy, or family therapy), or combination treatment. Approximately 50% of depressed youth in primary care decline pharmacotherapy, and adherence challenges are common. The evidence regarding antidepressant efficacy and safety is discussed with adolescents and families. Adequate treatment duration and dosing are ensured to achieve expected benefit, as many adolescents discontinue treatment prematurely.\n\n**Referral**\n\nReferral to [[94|mental health]] specialists is considered for severe depression, psychotic features, significant suicide risk, or when initial management in primary care is unsuccessful."
      }
    ]
  },
  {
    "article_id": 89,
    "article_title": "Growth & Puberty",
    "sections": [
      {
        "title": "Assessment of Pubertal Development",
        "content": "**Clinical evaluation:**\n\n1. **Obtain detailed history** including age of onset of breast development or testicular enlargement, pubic hair appearance, and age of menarche (if applicable)\n\n2. **Physical examination using Tanner staging:**\n   - Assess breast development (females): stages 1–5\n   - Assess testicular volume (males): note when volume reaches ≥4 cc (stage 2) or ≥12 cc (stage 3)\n   - Assess pubic hair development (both sexes): stages 1–5\n   - Measure height and plot on growth chart; assess growth velocity\n\n3. **Compare findings to age-appropriate norms:**\n   - Female thelarche: expected ages 8–15 years\n   - Male testicular enlargement: expected ages 10–15 years\n   - Peak height velocity timing relative to breast stage (females) or testicular stage (males)\n\n4. **Identify deviations** from expected sequence or timing that may warrant further investigation or specialist referral"
      }
    ]
  },
  {
    "article_id": 90,
    "article_title": "Pediatric Gastroenterology",
    "sections": [
      {
        "title": "Management of Acute Gastroenteritis",
        "content": "**Rehydration**\n\nOral rehydration therapy is the first-line approach in [[273|acute gastroenteritis]]. Intravenous rehydration may be used when oral rehydration is not feasible or has failed.\n\n**Feeding**\n\nEarly refeeding should be initiated as part of management of childhood gastroenteritis, following rehydration."
      }
    ]
  },
  {
    "article_id": 91,
    "article_title": "Pediatric Metabolic Disorders",
    "sections": [
      {
        "title": "Management of Neonatal Metabolic Disturbances",
        "content": "**Hypoglycemia**\n- Blood glucose is assessed urgently in at-risk infants (intrauterine growth restriction, infants of diabetic mothers)\n- Early treatment initiation is critical to prevent [[315|seizures]]\n- Duration of [[321|hypoglycemia]] and time to treatment are key determinants of neurological outcome\n\n**[[368|Hypocalcemia]]**\n- Infants are screened for [[368|hypocalcemia]] when low birthweight, born to diabetic mothers, asphyxiated, affected by DiGeorge syndrome, or born to mothers with hyperparathyroidism\n- Serum magnesium is assessed concurrently, as hypomagnesemia frequently accompanies hypocalcemia\n- Magnesium deficiency is corrected to facilitate calcium correction\n\n**[[170|Hyponatremia]]**\n- Fluid management practices are reviewed\n- Syndrome of inappropriate antidiuretic hormone secretion is evaluated for\n- Fluid intake and osmolarity are adjusted as indicated\n\n**Hypernatremia**\n- Feeding adequacy in breastfed infants is assessed\n- Correct formula dilution in formula-fed infants is verified\n- Underlying [[99|dehydration]] is addressed\n\n**Pyridoxine Dependency**\n- [[315|Seizures]] resistant to standard anticonvulsants are recognized as a clinical clue\n- Pyridoxine dependency is considered in infants with intrauterine convulsions\n- Specific treatment with pyridoxine may be indicated based on clinical suspicion and diagnostic confirmation"
      }
    ]
  },
  {
    "article_id": 92,
    "article_title": "Hypertension",
    "sections": [
      {
        "title": "Management",
        "content": "**Incidental Hypertension**\n\nManagement includes:\n- Pain control\n- Measures to calm the patient\n- Serial blood pressure monitoring\n\n**Diagnostic Approach**\n\n1. Blood pressure is measured by auscultation (not oscillatory devices) using an appropriately sized cuff for the patient's arm circumference\n2. Elevation is confirmed at three separate visits before hypertension is diagnosed\n3. In athletes with persistently elevated BP:\n   - Family history of hypertension is asked about\n   - Use of stimulants (caffeine, nicotine, ephedrine) or anabolic steroids is asked about\n   - In those <25 years with upper extremity hypertension, lower extremity BP is checked to exclude coarctation of the aorta\n4. 24-hour ambulatory blood pressure monitoring is considered to exclude white coat hypertension\n\n**Treatment**\n\nTarget blood pressure: less than the 90th percentile for sex, age, and height, or less than 130/80 mm Hg, whichever is lower.\n\nFirst-line approach: nutritional changes proven to treat hypertension. Pharmacological treatment is considered for those not responding to lifestyle modification."
      }
    ]
  },
  {
    "article_id": 93,
    "article_title": "Meconium Aspiration Syndrome",
    "sections": [
      {
        "title": "Management at delivery and resuscitation",
        "content": "**Initial assessment and airway management:**\n\nIf the infant cries at birth and establishes regular respiration, no resuscitation is required. If respiration is not established, initiating lung inflation within the first minute of life is the priority.\n\nFor infants born through meconium-stained fluid:\n- **Vigorous infants** (normal respiratory effort, heart rate, and tone): Routine tracheal suctioning is not recommended\n- **Non-vigorous infants** (decreased respiratory effort, heart rate, or tone): Direct tracheal suctioning is reasonable if meconium is present at delivery\n- Attempting to aspirate meconium from the nose and mouth while the infant's head is on the perineum is not recommended, as it is ineffective\n- If the infant becomes bradycardic, positive pressure ventilation to aerate the lungs is indicated despite the presence of meconium\n- If the baby was born through thick meconium, it is reasonable to inspect the oropharynx rapidly and remove any thick meconium by suctioning with a large-bore suction catheter\n\n**Ongoing respiratory support:**\n\nMechanical ventilation is often required. Extubation criteria include:\n- Peak inspiratory pressure of 12–14 cm H₂O (larger babies may be extubated with PIP 14)\n- Respiratory rate of 20–25 breaths per minute\n- FiO₂ requirement less than 40%\n\nExtubation to nasal CPAP or non-invasive positive pressure ventilation is especially useful in very low birth weight babies. Postextubation management includes periodic suctioning as needed, gentle chest physiotherapy, and nebulization with ipratropium to aid stabilization.\n\n**Advanced support:**\n\nHigh-frequency oscillatory ventilation and inhaled nitric oxide may be considered for infants with persistent pulmonary hypertension of the newborn who do not respond to conventional management."
      }
    ]
  },
  {
    "article_id": 94,
    "article_title": "Mental Health",
    "sections": [
      {
        "title": "Clinical Approach",
        "content": "**Screening and Identification**\n\nScreening for mental health concerns should be systematic and occur at multiple touchpoints:\n- Preparticipation physical evaluations\n- Every routine medical encounter\n- When concerning behaviors are observed during athletic participation or other activities\n\n**Assessment Setting**\n\nEnsure private, one-on-one discussion time between the young person and the healthcare provider. This is particularly important during telehealth visits to allow confidential assessment away from family members or others.\n\n**Recognition of Risk**\n\nBe alert to factors that may indicate mental health risk:\n- Performance-related stress (particularly in athletes)\n- Pressure to meet expectations from family, coaches, or peers\n- Recent injury or illness\n- Identity-related concerns\n- Social isolation or limited support networks\n- Behavioral changes during participation in activities\n\n**Management Considerations**\n\nWhen mental health concerns are identified, consider:\n- Referral to mental health specialists where available\n- Integration of care with primary care providers\n- Involvement of family and support systems\n- Recognition that emergency department and emergency medical services may be utilized when specialist access is limited\n\nNote: The passages provided do not contain specific medication dosing, psychotherapy protocols, or detailed treatment algorithms suitable for inclusion in this clinical section."
      }
    ]
  },
  {
    "article_id": 95,
    "article_title": "Pediatric Infectious Disease",
    "sections": [
      {
        "title": "Clinical Assessment and Management",
        "content": "**Initial Evaluation**\n\n- A detailed history including exposure history, incubation period considerations, and symptom timeline is obtained\n- A thorough physical examination documenting clinical manifestations is performed\n- Risk factors including immunocompromised status, underlying chronic conditions, or group care attendance are identified\n\n**Diagnostic Approach**\n\n- Pathogen-specific diagnostic tests are ordered based on clinical presentation and suspected organism\n- Incubation period is considered in timing of diagnostic testing\n- Findings are documented to guide organism identification\n\n**Treatment Considerations**\n\n- Antimicrobial therapy is selected based on identified or suspected organism\n- Age-appropriate dosing is used and route of administration is specified\n- Supportive care is provided, tailored to the infection type and severity\n- Complications and treatment response are monitored for\n\n**Special Populations**\n\n- Children with congenital heart disease or other chronic conditions may require modified prevention and treatment approaches\n- Immunocompromised hosts warrant specialized management strategies\n- Consultation with pediatric infectious disease specialists is considered for complex cases"
      }
    ]
  },
  {
    "article_id": 96,
    "article_title": "Vaccine-Preventable Diseases",
    "sections": [
      {
        "title": "Clinical Approach",
        "content": "**Identification and Management During Outbreaks**\n\nWhen vaccine-preventable diseases are suspected or confirmed:\n\n1. **Identify vaccination status** — Determine whether the child has been fully vaccinated according to the recommended childhood and adolescent vaccination schedule\n\n2. **Outbreak response** — During outbreaks of vaccine-preventable diseases, unvaccinated or undervaccinated children should be removed from schools and other congregate settings\n\n3. **Protect vulnerable contacts** — Identify very young infants and immunocompromised children who have had contact with the case, as these populations are at especially high risk for serious disease and cannot be completely immunized\n\n4. **Household contact assessment** — Evaluate parents and close family contacts for their vaccination status, as evidence suggests children are frequently exposed to pathogens through household transmission from inadequately protected adults\n\n**Note:** The reference passages do not provide specific clinical management protocols, diagnostic criteria, or treatment regimens for individual vaccine-preventable diseases. Disease-specific chapters should be consulted for clinical details."
      }
    ]
  },
  {
    "article_id": 97,
    "article_title": "Neonatal Hypoglycemia",
    "sections": [
      {
        "title": "Bedside Management",
        "content": "**Initial Assessment**\n\n1. [[321|hypoglycemia]] is confirmed: capillary glucose screening below 40 mg/dL is verified by laboratory serum or plasma glucose measurement\n2. In any sick infant, critical blood and urine samples are collected before treatment is started, to guide diagnosis\n3. Symptoms are assessed for: altered consciousness, poor feeding, apnea, cyanosis, hypothermia, hypotonia, tremor, or [[315|seizures]]\n\n**Treatment Approach**\n\n**For asymptomatic or mildly symptomatic infants:**\n- Early enteral feeding is initiated with human milk or standard infant formula (30–60 mL per feed)\n- Expected glucose rise: 20–30 mg/dL within the first hour\n- Frequent feeding is continued to maintain glucose homeostasis\n\n**For symptomatic hypoglycemia or failure of enteral feeding:**\n- Rapid intravenous correction is provided\n- 10% dextrose (D10W) is used intravenously\n- Treatment continues until normal glucose homeostasis is established and adequate substrate supply is secured\n\n**Monitoring and Targets**\n\n- First 48 hours: blood glucose is maintained >50 mg/dL\n- After 48 hours: blood glucose is maintained >60 mg/dL if intravenous glucose is required\n- Once blood glucose is stabilized, normal feedings resume\n- Infants unable to maintain preprandial glucose >50 mg/dL by 48 hours or >60 mg/dL after 48 hours require investigation for persistent [[321|hypoglycemia]] before discharge\n\n**Special Considerations**\n\n- Breastfed newborns have lower blood glucose and higher ketone concentrations compared to formula-fed infants\n- Suspected congenital hyperinsulinism requires genetic analysis and may require diazoxide or other medications for long-term control"
      }
    ]
  },
  {
    "article_id": 98,
    "article_title": "Allergic Rhinitis",
    "sections": [
      {
        "title": "Management",
        "content": "**Assessment**\n\nA detailed history of symptom onset, frequency, duration, and seasonal pattern is obtained. Potential allergen exposures (indoor and outdoor) are identified. Impact on sleep, school performance, and quality of life is assessed to determine severity classification. Physical examination of the nasal mucosa is performed, noting turbinate swelling and colour (red or pale pink-purple).\n\n**Pharmacological Treatment**\n\nFirst-line agents:\n- **Intranasal corticosteroids** — primary treatment option\n- **Antihistamines** — available in oral and intranasal formulations\n- **Leukotriene antagonists** — alternative or adjunctive therapy\n- **Decongestants** — for symptomatic relief\n- **Ipratropium nasal spray** — adjunctive therapy\n\n**Non-pharmacological Measures**\n\n- Nasal saline rinses wash away allergens\n- Allergen avoidance and environmental control (removing or reducing exposure to identified triggers)\n- For seasonal allergens, outdoor exposure is minimised during high pollen periods\n- For perennial indoor allergens, dust mite control measures are implemented and animal dander sources are removed where possible\n\n**Monitoring**\n\nResponse to treatment is assessed and therapy is adjusted based on symptom control and impact on quality of life. Treatment of nasal inflammation reduces associated asthma symptoms and emergency department visits in children with concurrent asthma."
      }
    ]
  },
  {
    "article_id": 99,
    "article_title": "Dehydration",
    "sections": [
      {
        "title": "Management",
        "content": "**Assessment and monitoring:**\n- A detailed history is obtained: duration of illness, frequency and character of vomiting/diarrhoea, urine output, preillness weight, recent oral intake\n- Vital signs, general appearance, oral mucosa, respiratory pattern, eyes (sunken appearance, tears), skin turgor, and capillary refill are examined\n- Fluid deficit is calculated: percentage dehydration × weight (kg) × 10 mL\n\n**Ongoing care:**\n- Physical examination and vital signs are reassessed continually\n- Urine output is monitored closely\n- Ongoing losses are quantified and replaced\n- Therapy is individualised based on dehydration type and severity\n\n**Admission criteria:**\n- [[161|Severe dehydration]] (>10% in infants; >6% in older children)\n- Inability to keep up with ongoing losses\n- Persistent hypoglycaemia\n- Appropriate outpatient care cannot be provided\n- Aetiology unclear and further workup required"
      }
    ]
  },
  {
    "article_id": 100,
    "article_title": "Myocarditis",
    "sections": [
      {
        "title": "Management",
        "content": "**Immediate actions:**\n- Immediate cardiology consultation is obtained to direct further workup and management\n- Hemodynamic monitoring is established to detect worsening cardiac function or shock\n- Serial physical examinations are performed, particularly between fluid boluses, as findings may become more obvious after fluid administration\n\n**Diagnostic workup:**\n- Electrocardiography (abnormal in >90% of cases)\n- High-sensitivity troponin T (highly sensitive for acute myocarditis)\n- Creatine phosphokinase level\n- Echocardiography to assess ventricular function and identify pericardial effusion\n- Chest radiography to evaluate for cardiomegaly\n\n**Supportive care:**\n- Treatment remains largely supportive unless a treatable infectious pathogen is identified\n- Patients with mild disease are observed for developing signs of [[285|congestive heart failure]]\n\n**Management of congestive heart failure** (under pediatric cardiologist guidance):\n- Diuretics\n- Angiotensin-converting enzyme inhibitors\n- Angiotensin II receptor antagonists\n- Beta-blockers\n\n**Management of arrhythmias:**\n- Arrhythmias are treated with appropriate medications\n- Temporary or permanent pacing is considered for persistent arrhythmias\n- Implantable cardioverter-defibrillator is considered for appropriate indications"
      }
    ]
  },
  {
    "article_id": 101,
    "article_title": "Normal Development",
    "sections": [
      {
        "title": "Clinical Assessment of Development",
        "content": "**Growth Monitoring**\n\nRegular measurement and plotting of length/height and weight on appropriate growth charts is fundamental to clinical practice. For children from birth to 2 years, WHO standards are used. For children aged 2 to 19 years, CDC growth charts are used. For children with genetic conditions (Down syndrome, Turner syndrome, Noonan syndrome), condition-specific growth charts are used. Any deviation from expected centiles or the normal sequence of development requires further assessment.\n\n**Motor Development Assessment**\n\nGross motor skills are examined by observing head control, ability to lift shoulders when prone, rolling, sitting balance, crawling, standing, and walking. Fine motor skills including visual tracking, reaching, grasping, and pincer grasp development are assessed. Findings are compared to age-appropriate milestones, noting that normal ranges exist around mean ages (e.g., walking: mean 12 months, normal range 9–17 months).\n\n**Early Intervention Referral**\n\nFormal developmental surveillance should include referral to early intervention programs, particularly for extremely low birth weight infants. Routine screening tests alone are not sensitive enough to detect subtle neurodevelopmental abnormalities. The Individuals with Disabilities Education Act Part C guarantees early intervention services for eligible infants and young children. By 3 months of adjusted age, vocalization beyond crying, visual tracking, reaching attempts, arm support, and head lifting are assessed for. By 6 months of adjusted age, sitting with support, head control, and arm positioning are assessed for."
      }
    ]
  },
  {
    "article_id": 102,
    "article_title": "Respiratory Distress Syndrome",
    "sections": [
      {
        "title": "Management",
        "content": "**Recognition and initial assessment**\n\nPrompt recognition of respiratory distress and early intervention prevent progression to respiratory failure and cardiorespiratory arrest. Clinical signs are identified: tachypnoea, grunting, nasal flaring, subcostal and intercostal retractions, and cyanosis.\n\n**Diagnostic confirmation**\n\nA chest radiograph is obtained to confirm diagnosis. Poor lung expansion with homogenous ground-glass appearance and air bronchograms is looked for.\n\n**Supportive care**\n\nSupplemental oxygen is provided as needed to maintain adequate oxygenation and reduce cyanosis.\n\n**Respiratory support**\n\nSevere cases require positive pressure ventilation. It is initiated based on clinical severity and blood gas abnormalities (progressive hypoxaemia and hypercarbia).\n\n**Surfactant replacement therapy**\n\nExogenous surfactant is administered in severe cases. This is a key intervention that has significantly improved survival rates.\n\n**Monitoring**\n\nOxygenation, ventilation status, and acid–base balance are continuously monitored. Response to therapy is assessed and support is adjusted accordingly."
      }
    ]
  },
  {
    "article_id": 103,
    "article_title": "Short Stature",
    "sections": [
      {
        "title": "Clinical Assessment and Management",
        "content": "**Initial evaluation:**\n\n1. **Measure and plot height** on age- and sex-appropriate growth charts; calculate mid-parental target height using parental heights\n2. **Assess growth velocity** by comparing current height to previous measurements; determine if child is following own curve or crossing percentiles downward\n3. **Determine pubertal status** using sexual maturity rating; this contextualizes growth velocity interpretation\n4. **Take detailed history** including birth weight and gestational age, family history of short stature or delayed puberty, chronic illness, nutritional intake, and family dynamics\n5. **Perform systematic physical examination** including:\n   - Head and eyes: hair quality, dysmorphism, midline defects, visual defects\n   - Face: tooth eruption, dysmorphic features\n   - Neck: webbing, goiter, low hairline\n   - Arm span measurement\n   - Hands and wrists: dermatoglyphics, abnormal fingers, [[325|rickets]]\n   - Chest: breast tissue, lung abnormalities\n   - Cardiovascular: blood pressure, heart abnormalities\n   - Abdomen: organomegaly, masses\n   - CNS: developmental assessment, features of brain tumor\n   - Genitalia: sexual maturity rating, hypogonadism, [[356|cryptorchidism]], micropenis\n   - Skin: birthmarks, pigmentation, fragility\n   - Body shape: muscle and fat distribution, asymmetry\n\n**Distinguishing normal from pathological short stature:**\n\nChildren with normal growth velocity, normal pubertal timing, and normal bone age—particularly those with short parents or family history of delayed puberty—typically have familial short stature or constitutional growth delay and do not require extensive investigation.\n\nChildren with decreased growth velocity, abnormal pubertal timing, or delayed bone age require further evaluation for pathological causes.\n\n**Further investigation when indicated:**\n\n- **Bone age:** Obtain if constitutional growth delay or pathological short stature is suspected\n- **Genetic evaluation:** Refer for genetic counseling and karyotype if dysmorphic features or syndromic appearance is present\n- **SHOX gene testing:** Consider in idiopathic short stature; if negative, pursue PAR1 deletion testing\n- **Laboratory studies:** Guided by clinical presentation and suspected etiology (thyroid function, growth hormone assessment, celiac serology, etc.)"
      }
    ]
  },
  {
    "article_id": 104,
    "article_title": "Failure To Thrive",
    "sections": [
      {
        "title": "Clinical Assessment and Management",
        "content": "**Growth Chart Plotting**\n\nAccurate serial measurement and plotting are the foundation of assessment:\n- Weight, length/height, and head circumference are plotted on WHO growth charts for children <2 years\n- For premature infants, gestation-corrected age is used:\n  - Weight: corrected until 24 months\n  - Head circumference: corrected until 18 months\n  - Length/height: corrected until 40 months\n- Standing height is recorded as height, not recumbent length\n- Crossing of percentile lines over 3–6 months or values below 3rd–5th percentile is identified\n\n**Comprehensive Evaluation**\n\nAssessment addresses multiple domains:\n- **Medical evaluation**: Organic causes (malabsorption, maldigestion, increased metabolic demand, ineffective calorie use) are identified\n- **Nutritional assessment**: Current intake is quantified and deficiencies are identified\n- **Psychosocial evaluation**: Family circumstances, feeding practices, parental knowledge, and emotional factors are assessed\n- **Developmental assessment**: Concurrent [[82|developmental delay]] is screened for\n\n**Multidisciplinary Management**\n\nEffective intervention requires coordinated input from:\n- Pediatrician or primary care provider\n- Registered dietitian\n- Social worker or family support specialist\n- Developmental specialist as indicated\n\nManagement is sustained beyond acute phases and tailored to address the specific medical, nutritional, and psychosocial factors contributing to [[246|growth failure]] in each child and family."
      }
    ]
  },
  {
    "article_id": 105,
    "article_title": "Pediatric Allergy And Immunology",
    "sections": [
      {
        "title": "Diagnostic Approach",
        "content": "**History and Examination**\n\nObtain detailed history documenting:\n- Timing and nature of symptoms (chronic versus acute onset)\n- Temporal relationship to antigen exposure\n- Seasonal patterns\n- Associated cutaneous findings ([[195|atopic dermatitis]], urticaria)\n- Respiratory symptoms (rhinorrhea, congestion, cough, wheezing, snoring)\n- Ocular symptoms (tearing, pruritus, injection)\n- Family history of allergic disease\n\n**Testing**\n\nWhen drug allergy is suspected, consider penicillin skin testing as a safe and effective evaluation tool in the pediatric population.\n\nFor suspected environmental or food allergens, allergen-specific IgE testing confirms sensitization and guides management decisions.\n\n**Primary [[122|Immunodeficiency]]**\n\nWhen primary immunodeficiency is suspected, evaluation should follow established practice parameters for diagnosis and management."
      }
    ]
  },
  {
    "article_id": 106,
    "article_title": "Pelvic Inflammatory Disease",
    "sections": [
      {
        "title": "Management",
        "content": "**First-line antibiotic regimens** (one option below is selected, then additional agents are added):\n\n**Option 1:**\n- Ceftriaxone 250 mg IM once\n\n**Option 2:**\n- Cefoxitin 2 g IM plus probenecid 1 g orally, both in a single dose concurrently\n\n**Option 3:**\n- Other parenteral third-generation cephalosporin (ceftizoxime or cefotaxime)\n\n**PLUS:**\n- Doxycycline 100 mg orally twice daily for 14 days\n\n**WITH or WITHOUT:**\n- Metronidazole 500 mg orally twice daily for 14 days\n\n**Diagnostic workup:**\n- A wet mount of vaginal secretions is performed to assess for white blood cells and to identify or exclude trichomonas or [[239|bacterial vaginosis]]\n- Gonococcal and chlamydial cervical infection are tested for\n- Serological testing for HIV and syphilis is performed\n- Imaging (transvaginal ultrasound or MRI) is considered if diagnosis is uncertain or to evaluate for complications such as tubo-ovarian abscess"
      }
    ]
  },
  {
    "article_id": 107,
    "article_title": "Asthma",
    "sections": [
      {
        "title": "Management",
        "content": "## Acute Exacerbation Management\n\nAsthma treatment is divided into two major categories:\n\n**Relievers (as-needed therapy):**\n- Short-acting beta-agonists (e.g., albuterol, levalbuterol) for quick relief of acute symptoms\n\n**Controllers (daily maintenance therapy):**\n- Inhaled corticosteroids (e.g., budesonide, fluticasone)\n- Leukotriene receptor antagonists (e.g., montelukast, zileuton)\n- Long-acting beta-agonists (LABAs; e.g., formoterol, salmeterol) — always paired with an inhaled corticosteroid, as LABAs alone increase morbidity\n- Single maintenance and reliever therapy (SMART) using combination inhalers with ICS and LABA (formoterol)\n\nTreatment regimens vary by age and are based on symptom severity (intermittent, mild persistent, or other classifications).\n\n## Severe Asthma and Status Asthmaticus\n\nIn severe asthma or status asthmaticus, endotracheal intubation is risky as these patients do not tolerate apnea well. Invasive mechanical ventilation is challenging due to air trapping, dynamic hyperinflation (auto-PEEP), risk of cardiovascular collapse, and ventilator-associated pneumonia.\n\nNon-invasive ventilation (NIV) may be beneficial, as it can unload respiratory muscles, offset intrinsic PEEP, recruit collapsed alveoli, stent small airways, decrease airflow resistance, minimize air-trapping, and improve delivery of aerosolized bronchodilators.\n\n## Poor Response to Therapy\n\nWhen children do not respond to standard therapy, consider:\n- Inhalation technique problems\n- Poor compliance with treatment plan\n- Exacerbating factors (tobacco smoke, [[245|gastroesophageal reflux]], sinusitis)\n- Alternative diagnoses ([[184|cystic fibrosis]], allergic bronchopulmonary aspergillosis, vocal cord dysfunction, hypersensitivity [[150|pneumonia]], sleep apnea)\n\nApproximately 5% of children require prolonged courses of corticosteroids to maintain a symptom-free period."
      }
    ]
  },
  {
    "article_id": 108,
    "article_title": "Chlamydia Infection",
    "sections": [
      {
        "title": "Diagnosis and Management",
        "content": "**Diagnostic approach:**\n\n- Nucleic acid amplification testing (NAAT) on urine or vaginal/endocervical swabs is obtained to confirm diagnosis\n- Test of cure is not performed; positive results persist for up to 3 weeks after treatment\n- Retesting is planned at 3 months even in asymptomatic patients due to high reinfection risk\n\n**Clinical assessment:**\n\n- Sexually active adolescents and young adults are screened\n- In prepubertal girls, vaginal discharge, vaginal bleeding, vulvar pruritus, pain, or erythema are assessed for\n- In adolescent girls, symptoms of cervical and urethral infection (pelvic/abdominal pain, spotting, irregular vaginal bleeding) are evaluated for\n- Coinfection with _Neisseria gonorrhoeae_ is tested for\n- In neonates born to infected mothers, conjunctivitis or signs of [[150|pneumonia]] are examined for\n\n**Note:** The reference passages do not provide specific antibiotic dosing regimens or routes of administration for treatment."
      }
    ]
  },
  {
    "article_id": 109,
    "article_title": "Transient Tachypnea Of Newborn",
    "sections": [
      {
        "title": "Bedside Management",
        "content": "**Initial Assessment**\n- Tachypnea (respiratory rate 80–100 breaths/min) with shallow, rapid breathing is confirmed\n- Chest retractions (typically minimal or absent) are assessed for\n- Cyanosis is evaluated for\n- Maternal history is obtained: mode of delivery, labor analgesia/anesthesia, gestational diabetes, [[107|asthma]], [[92|hypertension]]\n\n**Diagnostic Workup**\n- A chest radiograph is obtained to identify characteristic findings: bilateral streaky opacities, hyperinflation, possible pleural fluid\n- Other diagnoses are excluded: maternal [[355|chorioamnionitis]], maternal infection, meconium staining, premature rupture of membranes, [[226|sepsis]]\n- Clinical judgment is essential as radiographs cannot reliably differentiate TTN from neonatal [[150|pneumonia]]\n\n**Supportive Care**\n- Normal newborn care and feeding support are provided\n- Oxygen is administered for mild cyanosis as needed\n- Normal oral feeding is maintained when the infant is stable\n- Respiratory status and clinical improvement are monitored\n- Furosemide or inhaled racemic epinephrine is not used (no proven benefit)\n\n**Follow-up**\n- Symptom resolution is expected by 12–24 hours in most infants; 74% resolve by 48 hours\n- Respiratory symptoms typically disappear by 3 days\n- Radiographic resolution occurs within 24–48 hours\n- In healthy asymptomatic infants, follow-up radiographs are not necessary\n- Prolonged tachypnea (>72 hours) or deteriorating clinical status is investigated with further evaluation"
      }
    ]
  },
  {
    "article_id": 110,
    "article_title": "Abnormal Uterine Bleeding",
    "sections": [
      {
        "title": "Management",
        "content": "**Initial Assessment**\n\n1. Diagnosis and severity are confirmed\n   - Hemodynamic status and degree of [[349|anemia]] are assessed\n   - Severity is categorized as mild, moderate, or severe\n\n2. Life-threatening causes are excluded\n   - Urine hCG (pregnancy test) in all patients\n   - Complete blood count including platelets and reticulocyte count\n   - Coagulation studies: prothrombin time, partial thromboplastin time, von Willebrand panel (especially if bleeding began at menarche or is severe)\n   - Thyroid function tests (free T4, TSH)\n   - Sexually transmitted infections are screened for in at-risk patients\n\n3. Additional investigations are considered\n   - Pelvic ultrasound if structural pathology is suspected\n   - Follicle-stimulating hormone, luteinizing hormone, prolactin as clinically indicated\n\n**Treatment**\n\n- Acute management typically consists of hormonal therapy tailored to severity and etiology\n- High-dose estrogen therapy requires concurrent antiemetic medication\n- A menstrual calendar (paper or smartphone app) is maintained to monitor response to therapy"
      }
    ]
  },
  {
    "article_id": 111,
    "article_title": "Attention-Deficit/Hyperactivity Disorder",
    "sections": [
      {
        "title": "Clinical Approach",
        "content": "**Screening and Evaluation**\n\nScreen all children aged 4 to 18 years presenting with academic or behavioural concerns for ADHD and common comorbid conditions including depression, anxiety, oppositional defiant disorder, and [[286|conduct disorder]].\n\n**Diagnostic Assessment**\n\nConfirm that three diagnostic criteria are met:\n\n1. Persistent pattern of inattention and/or hyperactivity-impulsivity that is developmentally inappropriate\n2. Symptoms present before at least 7 years of age\n3. Symptoms occurring across multiple settings (not limited to home or school alone)\n\nAssess the degree to which symptoms interfere with the child's social, academic, and functional performance.\n\n**Comorbidity Screening**\n\nWhen ADHD is identified or suspected, evaluate for coexisting conditions:\n- Reading disability\n- Oppositional defiant disorder\n- [[286|Conduct disorder]]\n- Anxiety disorder\n- Depressive disorder\n\nThe passages provided do not include specific medication dosing, routes, or detailed treatment protocols beyond the identification of ADHD and its comorbidities."
      }
    ]
  },
  {
    "article_id": 112,
    "article_title": "Medication Error",
    "sections": [
      {
        "title": "Preventing medication errors at the bedside",
        "content": "**Before prescribing or preparing any medication:**\n\n1. **The child's weight is confirmed** and included in all verbal and written orders.\n2. **Closed-loop communication is used**: the drug name, dose with units, route, and child's weight are stated; the recipient is asked to repeat back the intended dose.\n3. **For oral liquid medications**, prescribing and administration use **millilitres only**. Teaspoons or tablespoons are not used. The child's carer is given a **syringe marked in metric units** rather than a household spoon.\n4. **For high-risk drugs** (such as epinephrine in neonatal emergencies), it is ensured that **only one concentration is available** in the clinical area. For neonatal resuscitation, only the **dilute epinephrine solution (0.1 mg/mL)** is stocked; the concentrated solution (1 mg/mL) should not be present, as accidental use causes a 10-fold overdose.\n5. **The concentration is verified** by showing the medication box to another team member before preparation.\n6. **The prepared dose is checked** against a weight-based reference chart or table.\n7. **Ambiguous abbreviations are avoided** and prescriptions state both the drug name and its concentration (not volume alone).\n8. **Intravenous line patency is verified** before any medication is injected, and endotracheal tube position is confirmed before drugs are administered via that route."
      }
    ]
  },
  {
    "article_id": 113,
    "article_title": "Fever Of Unknown Origin",
    "sections": [
      {
        "title": "Management",
        "content": "**Initial Assessment and Investigation**\n\n1. **History and Examination**\n   - Obtain detailed surgical history (dental, abdominal, cardiac)\n   - Document travel history and prophylaxis taken\n   - Assess exposures: ill contacts, animals, insect/tick bites, water sources, soil/artifacts from distant areas\n   - Review medications (including topical and household) and dietary history (raw/undercooked meat, unpasteurized milk)\n   - Perform physical examination while febrile if possible\n   - Examine for rash appearance with fever, sweating pattern, growth parameters, skin findings, conjunctivitis, dental abnormalities, pharyngeal injection, gingival changes, arthritis, bone/muscle tenderness\n   - Perform pelvic examination in sexually active females\n   - Perform rectal examination and check stool for occult blood\n\n2. **First-Line Investigations**\n   - Complete blood count\n   - Chest X-ray\n   - Urinalysis\n   - Blood culture\n   - Malarial parasite testing\n   - C-reactive protein\n\n3. **Interpretation of CBC**\n   - WBC <5,000/cu mm: suspect [[232|viral infection]], dengue, or enteric fever\n   - WBC <15,000/cu mm: continue observation; if fever persists >48 hours without localizing findings, proceed to comprehensive evaluation\n\n4. **Respiratory Symptoms**\n   - If prolonged upper or lower respiratory symptoms present: obtain chest X-ray and sinus imaging (CT or plain radiography) regardless of symptom severity\n\n5. **[[152|Tuberculosis]] Evaluation**\n   - Perform tuberculin skin testing and interferon gamma release assay\n   - Note: up to 50% of disseminated TB may show negative tuberculin skin test and negative interferon gamma release assay results\n   - Consider bone marrow biopsy if skin testing and lab testing are negative or inconclusive\n\n6. **Further Investigation**\n   - If initial investigations negative or inconclusive: consider bone marrow biopsy\n   - Abdominal ultrasound as part of comprehensive evaluation when indicated"
      }
    ]
  },
  {
    "article_id": 114,
    "article_title": "Learning Disability",
    "sections": [
      {
        "title": "Assessment and Referral",
        "content": "**Screening and Initial Assessment**\n\nWhen a child presents with academic difficulties or a teacher raises concerns about learning:\n\n1. **Take a detailed history** of academic performance, including specific areas of difficulty (reading, writing, mathematics), age of onset, and response to any previous interventions or tutoring\n\n2. **Screen for coexisting conditions** using validated tools such as the Vanderbilt ADHD Rating Scale, as ADHD and learning disabilities frequently coexist but require different management approaches\n\n3. **Verify adequate sensory function** by confirming that vision and hearing have been recently assessed and are adequate for learning\n\n4. **Exclude other causes** of academic difficulty: [[212|intellectual disability]], neurological or [[94|mental health]] disorders, psychosocial stressors, limited proficiency in the language of instruction, or inadequate educational opportunity\n\n5. **Document the child's response to evidence-based instruction** in school, including whether targeted interventions have been provided and for how long\n\n**Referral for Formal Evaluation**\n\nIf screening suggests a possible learning disability, refer the child for comprehensive psychoeducational evaluation. This is typically not available in primary care and should be conducted by:\n- School psychologists (via the school system)\n- Clinical psychologists trained in learning disability assessment\n- Other specialists trained in comprehensive learning disability evaluation\n\nAdvise parents that formal evaluation will include standardized achievement testing, cognitive ability testing, and clinical assessment to establish whether academic skills are substantially and measurably below age expectations and to identify the specific nature of the learning difficulty."
      }
    ]
  },
  {
    "article_id": 115,
    "article_title": "Congenital Anomalies",
    "sections": [
      {
        "title": "Management",
        "content": "**Immediate Assessment**\n\nInfants with congenital anomalies require early recognition and systematic evaluation. Upon identification of any anomaly, whether it is an isolated finding or part of a multiple malformation syndrome is determined, as this distinction guides further investigation and prognosis.\n\n**Genetic Testing**\n\nInfants with congenital anomalies warrant genetic testing. Testing strategies include:\n- Karyotyping to identify large chromosomal abnormalities\n- Fluorescence in situ hybridization (FISH) for classic microdeletion syndromes such as 22q11\n- Chromosomal microarray for comprehensive genetic assessment\n\n**Life-Threatening Anomalies Requiring Immediate Intervention**\n\nThe following anomalies require immediate medical or surgical therapy for postnatal survival:\n- Congenital heart disease\n- Tracheoesophageal fistula\n- Congenital diaphragmatic hernia\n- Choanal atresia\n- [[302|Intestinal obstruction]]\n\nThese conditions necessitate delivery room preparation and coordination with surgical services.\n\n**Clinical Evaluation Strategy**\n\nWhen multiple minor anomalies are identified, thorough clinical assessment is performed to exclude occult major defects. The presence of multiple minor findings significantly increases the probability of identifying significant underlying anomalies. All findings are documented systematically by organ system to facilitate syndrome recognition and genetic counseling."
      }
    ]
  },
  {
    "article_id": 116,
    "article_title": "Pediatric Critical Care",
    "sections": [
      {
        "title": "Management Approach",
        "content": "**Recognition and Initial Assessment**\n\nSigns of shock are identified early, as prompt intervention significantly improves outcomes. Tissue perfusion, mental status, and hemodynamic parameters are assessed continuously.\n\n**Fluid Resuscitation**\n\nFor pediatric [[178|septic shock]], resuscitation with balanced fluids is initiated. This approach is associated with improved survival compared to alternative fluid strategies.\n\n**Hemodynamic Support**\n\nHemodynamic support is provided, tailored to the type and severity of shock. American College of Critical Care Medicine clinical practice parameters for pediatric and neonatal septic shock are followed to guide the intensity and type of support required.\n\n**Advanced Life Support**\n\nPediatric Advanced Life Support guidelines are adhered to. Age- and weight-appropriate dosing is used for resuscitation medications as outlined in current guidelines.\n\n**Monitoring for Complications**\n\nRegular screening for delirium uses validated assessment tools such as the Cornell Assessment of Pediatric Delirium, which provides rapid observational screening in the PICU setting.\n\n**Transport Considerations**\n\nWhen interfacility transport is necessary, the transport team must have specialized pediatric knowledge and appropriate equipment. Telemedicine support is considered to facilitate consultation during transfer."
      }
    ]
  },
  {
    "article_id": 117,
    "article_title": "Autism Spectrum Disorder",
    "sections": [
      {
        "title": "Clinical Management",
        "content": "**Hospitalization and Physical Examination**\n\nWhen a child with autism spectrum disorder requires hospitalization, a complete physical examination is conducted, as these patients remain at risk for the full range of pathology. The examination may be tailored based on the history obtained and the patient's current status.\n\n**Key Clinical Considerations:**\n\n- The patient's communication assist devices or comfort items are used during examination and care\n- If the presenting complaint relates to pain or agitation, specific attention is paid to organ systems that may be involved\n- Common comorbidities that may require hospitalization in patients with autism spectrum disorder are recognized\n- Physical and neurologic examinations are typically completely normal in autism spectrum disorder\n\n**Intervention Approach**\n\nBest practice management includes:\n\n1. Systematic assessment of the child's existing skills\n2. Selection of individualized, measurable goals based on objective assessment\n3. Use of assessment-based, empirically supported instructional methods to build, generalize, and maintain skills and reduce problem behaviors\n4. Inclusion of specific intervention content addressing impairments in social communication and restricted and repetitive behavioral patterns"
      }
    ]
  },
  {
    "article_id": 118,
    "article_title": "Behavioral Disorder",
    "sections": [
      {
        "title": "Assessment and Management",
        "content": "**Initial Assessment**\n\nWhen a child presents with suspected [[286|conduct disorder]] or acute behavioral disturbance, a detailed behavior history is obtained from parents and caregivers, as children rarely self-report these concerns. The onset, duration, and settings in which behaviors occur are assessed. Any acute changes in behavior are screened for, particularly if accompanied by physical symptoms or abnormal vital signs, as medical conditions may contribute to or complicate the presentation.\n\nThe differential diagnosis is considered, which includes anxiety, adjustment reactions, depression, mania, medical illness (including delirium), pervasive developmental disorders, psychosis, and trauma. A thorough medical evaluation is warranted to exclude organic causes of behavioral change.\n\n**Diagnostic Evaluation**\n\nSymptoms are confirmed to meet criteria: at least 3 of 15 conduct disorder criteria present in the past 12 months, with at least one in the past 6 months. The specific behaviors observed and reported are documented. Age of onset (before or after age 10 years) is determined, as this significantly affects prognosis and management planning.\n\n**Risk Stratification**\n\nChildren at increased risk for substance abuse and trauma-related injuries are identified. Suicidal ideation and homicidal risk are assessed for, particularly in high-risk patients. Comorbid psychiatric conditions and medical contributors are evaluated for.\n\n**Management Approach**\n\nBecause children do not typically seek help independently, parents and caregivers are engaged as active partners in treatment planning. Behavioral management counseling services, including in-home behavior management counseling, should be considered. Care is coordinated across school, home, and community settings, as symptoms may be confined to specific environments. Any identified medical or psychiatric comorbidities are addressed. For acute agitation or aggression requiring emergency department evaluation, management follows acute behavioral emergency protocols while underlying medical or psychiatric triggers are investigated."
      }
    ]
  },
  {
    "article_id": 119,
    "article_title": "Pediatric Neurology",
    "sections": [
      {
        "title": "Clinical Assessment at the Bedside",
        "content": "**History Taking**\n\nA systematic history is taken focusing on:\n- Timing and mode of symptom onset (acute vs. gradual)\n- Course of illness (stable, progressive, or fluctuating)\n- Antenatal history: maternal infections, drug exposure, complications\n- Perinatal history: delivery method, need for resuscitation, Apgar scores\n- Neonatal history: birth weight, [[321|hypoglycemia]], [[368|hypocalcemia]], jaundice, feeding difficulties, early activity abnormalities\n- Developmental history: achievement of motor and cognitive milestones, any regression\n- Family history of neurologic or genetic disorders\n\n**Physical Examination**\n\nA systematic neurologic examination adapted to developmental stage is conducted:\n- Level of consciousness and behavior are assessed\n- Cranial nerves (II–XII) are evaluated\n- Motor function is tested: tone, strength, spontaneous movement\n- Reflexes are assessed and symmetry is compared\n- Coordination and gait are evaluated (if age-appropriate)\n- Sensory testing is performed as tolerated\n- Abnormal movements or posturing are looked for\n- Head circumference is measured in infants and young children\n\n**When to Pursue Further Investigation**\n\nNeuroimaging (cranial ultrasound or MRI) is considered when:\n- Abnormal neurologic findings on examination\n- [[82|Developmental delay]] or regression\n- Suspected structural brain abnormality\n- History of significant perinatal insult\n\nSpecialized testing (nerve conduction studies, electromyography, genetic/metabolic panels) is considered based on clinical presentation and suspected diagnosis."
      }
    ]
  },
  {
    "article_id": 120,
    "article_title": "Pediatric Psychiatry",
    "sections": [
      {
        "title": "Assessment and Management",
        "content": "**Initial Evaluation**\n\nA structured interview and mental status examination are conducted in all patients presenting with suspected psychiatric emergencies. Hallucinations and psychotic symptoms are assessed for through careful questioning about perceptual experiences and thought content.\n\n**Risk Stratification**\n\nPatients at high risk for psychiatric boarding (prolonged medical ward stays) are identified early in the emergency department course. Predictors include acute suicidal ideation, suicide attempts, and acute psychotic symptoms. Early identification allows for timely psychiatric consultation and disposition planning.\n\n**Coordination of Care**\n\nPrompt psychiatric evaluation is arranged for patients requiring inpatient admission. Coordination with psychiatric services minimizes boarding time on medical wards. Clinical indicators that necessitate psychiatric hospitalization versus outpatient follow-up are documented.\n\n**Special Populations**\n\nFor children and adolescents following disasters or traumatic events, a public [[94|mental health]] approach is implemented through the emergency department. Crisis support is provided and families are connected to ongoing mental health resources in the community."
      }
    ]
  },
  {
    "article_id": 121,
    "article_title": "Pediatric Cardiology",
    "sections": [
      {
        "title": "Clinical Assessment and Management",
        "content": "**Initial Evaluation**\n\nEvaluation begins with a focused history addressing the presenting complaint, family history of cardiac disease, and functional capacity. Systematic physical examination is performed, including vital signs with age-appropriate blood pressure measurement, cardiac auscultation for murmurs and abnormal sounds, and assessment for signs of heart failure such as hepatomegaly or peripheral edema.\n\n**Diagnostic Testing**\n\nElectrocardiography is interpreted using age-specific normal standards for infants and children. Imaging is selected based on clinical suspicion: echocardiography for initial structural assessment, cardiac MRI or CT for detailed anatomical definition when needed, and chest radiography to evaluate cardiac silhouette and pulmonary vascularity.\n\n**Chest Pain Evaluation**\n\nMost pediatric chest pain referrals represent low-probability cardiac cases. Detailed characterization of pain quality, duration, triggers, and associated symptoms is obtained. Thorough physical examination and electrocardiography are performed. Reassurance and explanation of benign findings often suffice; cardiac imaging is reserved for cases with clinical features suggesting organic disease.\n\n**Blood Pressure Management**\n\nBlood pressure is measured using an appropriately sized cuff with the child seated and at rest. Readings are compared to age, sex, and height-specific reference standards. Elevated readings warrant confirmation on repeat visits before pharmacological intervention is initiated.\n\n**Murmur Assessment**\n\nMurmurs are characterized by timing (systolic, diastolic, continuous), location, radiation, quality, and intensity. Findings are correlated with clinical context, including growth and development, exercise tolerance, and associated symptoms. Innocent murmurs typically have characteristic features that distinguish them from pathological lesions; echocardiography confirms the diagnosis when clinical uncertainty exists."
      }
    ]
  },
  {
    "article_id": 122,
    "article_title": "Immunodeficiency",
    "sections": [
      {
        "title": "Clinical Evaluation and Management",
        "content": "**Initial Assessment**\n\nPrimary immunodeficiency is suspected in children presenting with:\n- Recurrent infections requiring intravenous antibiotics\n- Recurrent deep-seated infections\n- Chronic oral or cutaneous candidiasis\n- Chronic diarrhoea with atypical features\n- Complications from live vaccines\n- Autoimmune disease or malignancy\n\n**Diagnostic Workup**\n\n1. A detailed infection history is obtained (frequency, severity, type, response to treatment)\n2. Serum immunoglobulin levels (IgG, IgA, IgM) are measured\n3. Specific antibody responses are assessed\n4. B and T cell enumeration and functional studies are performed\n5. Molecular genetic testing is considered based on clinical phenotype\n6. Referral to an immunologist is made for diagnosis confirmation and assessment of the degree of immunodeficiency\n\n**Immunisation Strategy**\n\nVaccine approach depends on immunodeficiency category:\n\n- **Selective IgA deficiency**: All live-virus and inactivated vaccines are given as per standard schedule\n- **Major antibody deficiencies or SCID on immunoglobulin therapy**: Routine inactivated vaccines are avoided (except inactivated [[298|influenza]] vaccine); inactivated vaccines may be given as part of pre-therapy immunologic assessment\n- **Common variable immunodeficiency**: Annual inactivated influenza vaccine is given; meningococcal conjugate vaccine (MenACWY) is begun at 2 months of age due to splenic dysfunction and inadequate meningococcal antibody coverage in immunoglobulin replacement\n\n**Ongoing Management**\n\nCare is coordinated with an immunologist for:\n- Immunoglobulin replacement therapy decisions\n- Monitoring for complications (malignancy, autoimmunity, progressive organ involvement)\n- Gastrointestinal surveillance in conditions with known GI manifestations\n- Genetic counselling for family members"
      }
    ]
  },
  {
    "article_id": 123,
    "article_title": "Pediatric Pulmonology",
    "sections": [
      {
        "title": "Assessment and Monitoring",
        "content": "**Initial Evaluation**\n\nSystematic pulmonary physical examination should be performed in all children with respiratory symptoms or suspected pulmonary disease. This includes assessment of work of breathing, auscultatory findings, and signs of respiratory distress.\n\n**Imaging and Diagnostic Studies**\n\nImaging selection depends on clinical presentation:\n- Chest radiography for initial assessment of acute conditions and to evaluate for complications such as [[396|pneumothorax]] or pleural effusion\n- High-resolution computed tomography for detailed evaluation of parenchymal disease, air-trapping, and structural abnormalities\n- Soft tissue neck radiographs when pharyngeal narrowing is suspected\n- Flexible bronchoscopy to assess dynamic airway changes when indicated\n\n**Monitoring in Chronic Disease**\n\nIn severe forms of systemic disease affecting the lungs (such as mucopolysaccharidosis type I), polysomnography is suggested yearly; in milder forms (such as mucopolysaccharidosis type II), polysomnography every 3 to 5 years is recommended to assess for sleep-related respiratory complications."
      }
    ]
  },
  {
    "article_id": 124,
    "article_title": "Pediatric Endocrinology",
    "sections": [
      {
        "title": "Management Approach",
        "content": "**Initial Assessment**\n\nSystematic evaluation begins with detailed history including age of symptom onset, growth trajectory, pubertal development, family history of endocrine disorders, and nutritional intake. Physical examination documents growth parameters, pubertal staging, and signs of specific endocrine dysfunction.\n\n**Hyperglycemia in Extremely Low Birth Weight Infants**\n\nInfants with birth weight less than 1600 g receiving parenteral nutrition may develop hyperglycemia. Insulin infusion should be considered as part of parenteral nutrition management when hyperglycemia occurs.\n\n**Nutritional Support in Critical Illness**\n\nVery low birth weight infants benefit from early trophic feeding prior to advancement to full enteral nutrition. Gastrointestinal priming strategies support tolerance of advancing feeds. In infants with congenital heart disease and [[246|growth failure]], enteral nutrition with appropriate energy density supports growth while managing cardiac status.\n\n**Pubertal Disorders**\n\nCentral [[222|precocious puberty]] management may include gonadotropin-releasing hormone analogs. Treatment decisions require assessment of pubertal progression rate and consideration of psychological and social factors.\n\n**Referral Considerations**\n\nComplex endocrine disorders, including intersex conditions, [[136|congenital adrenal hyperplasia]], and disorders of pubertal timing, warrant evaluation by a pediatric endocrinologist. Multidisciplinary management involving genetics, urology, psychology, and other specialties may be necessary for optimal outcomes."
      }
    ]
  },
  {
    "article_id": 125,
    "article_title": "Pertussis",
    "sections": [
      {
        "title": "Management",
        "content": "**Diagnosis and initial assessment**\n\n- Nasopharyngeal secretions are obtained for PCR or culture to confirm diagnosis\n- Complete blood count is performed; leukocytosis with absolute lymphocytosis is expected (though this may be absent in infants)\n- Chest radiograph is obtained; obliteration of cardiac borders or signs of [[150|pneumonia]] and atelectasis are sought\n- In infants, the characteristic inspiratory whoop may be absent and classic laboratory findings may not be present\n\n**Clinical evaluation**\n\n- Paroxysmal cough pattern and posttussive vomiting are assessed\n- [[151|Respiratory distress]], cyanosis, apnea, bradycardia, and poor feeding are monitored for in infants\n- Complications including [[150|pneumonia]], [[315|seizures]], and signs of secondary [[278|bacterial infection]] are evaluated\n- [[226|Sepsis]] in infants is distinguished by the paroxysmal cough pattern on examination\n- Auscultation of the chest is usually normal despite severe cough\n\n**Infection control**\n\n- Pertussis is highly communicable during the catarrhal and early paroxysmal cough stages (approximately 4 weeks after onset)\n- Appropriate respiratory isolation precautions are implemented"
      }
    ]
  },
  {
    "article_id": 126,
    "article_title": "Ventricular Septal Defect",
    "sections": [
      {
        "title": "Clinical Assessment and Management",
        "content": "**Initial Evaluation**\n\nThe infant is assessed for signs of heart failure: failure to thrive, tachypnea, diaphoresis during feeding, hepatomegaly, and poor feeding tolerance. These symptoms typically emerge at 3–6 months of age in infants with large defects.\n\nCardiac auscultation identifies a pansystolic murmur (which masks the first heart sound), and a thrill is palpated for. Small defects may produce no murmur.\n\n**Diagnostic Confirmation**\n\nEchocardiography is the primary diagnostic modality. Apical four-chamber views are used for perimembranous defects and short-axis views for muscular defects. Color flow Doppler interrogation is performed, particularly for small muscular defects in the apical region.\n\nA chest radiograph is obtained to assess for cardiomegaly, left atrial enlargement, and increased pulmonary artery flow.\n\n**Management Strategy**\n\n**Small defects** (< 3 mm): Clinical observation is appropriate. No intervention is required in most cases, as spontaneous closure occurs in the majority. Follow-up echocardiography can be performed to document closure.\n\n**Large defects** (6–10 mm) with normal pulmonary vascular resistance and symptoms of heart failure: Surgical evaluation is warranted. Surgery is performed before age 2 years to prevent the development of pulmonary vascular obstructive disease.\n\n**Timing of intervention** depends on the clinical situation. Infants with symptoms of failure to thrive, significant tachypnea, and poor feeding at 3–6 months of age require correction at that time."
      }
    ]
  },
  {
    "article_id": 127,
    "article_title": "Acute Lymphoblastic Leukemia",
    "sections": [
      {
        "title": "Management of Acute Presentation",
        "content": "**Initial Assessment and Emergency Management**\n\nWhen a greatly elevated leukocyte count is identified (particularly >100,000/μL with symptoms), this constitutes a medical emergency requiring immediate intervention to prevent leukostasis.\n\n**Management of Leukostasis**\n\nIf leukostasis is suspected (symptoms: hypoxemia, mental status changes), immediately initiate measures to reduce leukocyte count:\n\n- Chemotherapy: hydroxyurea (specific dosing not provided in passages)\n- Exchange transfusion\n- Leukopheresis\n\n**Induction Chemotherapy Phase**\n\nRemission-induction therapy is initiated following diagnosis confirmation. This phase is associated with:\n\n- Prolonged cytopenias lasting 3–5 weeks\n- Risk of infectious or hemorrhagic complications in 2–5% of patients during this period\n- Monitoring for early response: blast clearance from peripheral blood by day 7 and from bone marrow by day 14 indicates favorable prognosis\n\n**Risk-Based Treatment Intensification**\n\nTreatment intensity is tailored based on risk stratification:\n\n- **Standard-risk patients** (age 2–10 years, WBC ≤50,000/mm³): standard chemotherapy regimens\n- **High-risk patients** (age <1 or >10 years, WBC >50,000/mm³, CNS/testicular involvement, slow early response, adverse cytogenetics): intensified chemotherapy\n- **Infant ALL** (age <1 year): more intensive chemotherapy than older children\n\n**Monitoring During Induction**\n\nClose surveillance is essential during the 3–5 week induction phase for early detection and management of infectious and hemorrhagic complications."
      }
    ]
  },
  {
    "article_id": 128,
    "article_title": "Ankle Sprain",
    "sections": [
      {
        "title": "Management",
        "content": "**Initial Assessment**\n\n1. Point tenderness over the anterior talofibular ligament and calcaneofibular ligament is examined for\n2. Passive inversion is tested—marked pain indicates ligament injury\n3. Weight-bearing ability is assessed; most children can bear slight weight\n4. X-rays are obtained in skeletally immature athletes to exclude fracture\n\n**Acute Phase (First 48–72 Hours)**\n\n- **Protection and immobilization**: An air splint, elastic wrap, or ankle stirrup brace is applied to support the ankle in a functional position (right angle)\n- **Rest**: Ambulation or exercise is allowed only if it causes no pain or swelling during activity or within 24 hours. Crutches and light weight-bearing are used if pain occurs\n- **Ice**: Applied directly to the ankle for 20 minutes every 2 hours for the first 48 hours\n- **Compression**: Elastic wrap or air splint provides compression\n- **Elevation**: The extremity is elevated to reduce swelling\n- **NSAIDs**: Included as part of the treatment regimen\n\n**Rehabilitation**\n\n- Functional rehabilitation begins as soon as possible\n- Focus is on edema control, range of motion, strengthening, and proprioceptive restoration\n- Weight-bearing progresses as tolerated\n- Formal physical therapy is arranged\n- A lace-up ankle brace is prescribed for ongoing support and prevention of recurrence"
      }
    ]
  },
  {
    "article_id": 129,
    "article_title": "Dysfunctional Uterine Bleeding",
    "sections": [
      {
        "title": "Management",
        "content": "**Initial Assessment**\n\n1. A detailed menstrual history is obtained: age at menarche, cycle length, duration of flow, volume of bleeding, and pattern of bleeding\n2. Bleeding risk is screened for: history of easy bruising, nosebleeds, family history of bleeding disorders, and heavy bleeding in relatives\n3. Complete physical examination is performed, including vital signs, assessment for pallor or signs of [[349|anemia]], thyroid palpation, and pelvic examination as appropriate\n4. Hemoglobin or hematocrit is measured\n\n**Stratification and Management**\n\n| Clinical Scenario | Management |\n|---|---|\n| Mild bleeding, normal hemoglobin, no contraceptive need | Observation and reassurance |\n| Low hemoglobin level (with or without other signs of iron deficiency) | Iron supplementation |\n| Symptomatic anemia or actively bleeding | Hospitalization |\n\n**Pharmacologic Options**\n\n- **Nonsteroidal anti-inflammatory drugs**: Ibuprofen or naproxen are used to reduce menstrual flow\n- **Combined hormonal contraceptives**: Highly effective for reducing or eliminating abnormal bleeding when appropriate for the adolescent\n\n**Further Investigation**\n\nBased on clinical findings, further testing may include:\n\n- Thyroid function tests if thyroid dysfunction is suspected\n- Coagulation studies if there is a personal or family history of bleeding disorder\n- Testing for sexually transmitted infections if intermenstrual bleeding or risk factors are present\n- Pelvic ultrasound if structural pathology is suspected"
      }
    ]
  },
  {
    "article_id": 130,
    "article_title": "Hyperbilirubinemia",
    "sections": [
      {
        "title": "Management",
        "content": "**Assessment and Measurement**\n\nMeasure total serum bilirubin (TSB) or transcutaneous bilirubin (TcB) in all newborns. Plot the result on an age-specific nomogram using postnatal age in hours and gestational age to determine risk category (no hyperbilirubinemia, neurotoxicity risk, or high-risk zone).\n\nFor infants of diabetic mothers, measure bilirubin earlier and more frequently than age-matched controls. Continue monitoring for up to 5 to 7 days of life, as bilirubin peaks later in this population.\n\n**Risk Stratification**\n\nIdentify risk factors at birth and predischarge:\n- Predischarge TSB or TcB in high-risk or high-intermediate risk zone\n- Gestational age 34 0/7 to 36 6/7 weeks\n- Exclusive breastfeeding with poor latch or excessive weight loss\n- Jaundice in first 24 hours of life\n- Isoimmune or hemolytic disease (including G6PD deficiency)\n- Sibling history of neonatal jaundice or phototherapy\n- East Asian ethnicity\n- Polycythemia, [[283|cephalohematoma]], or bruising\n- Infants of diabetic mothers\n\n**Phototherapy**\n\nInitiate phototherapy when TSB reaches the age-specific threshold for the infant's gestational age and postnatal age in hours. Thresholds vary by gestational age (ranging from ≥35 weeks to <35 weeks) and increase with postnatal age.\n\n**Exchange Transfusion**\n\nPerform immediate exchange transfusion in any infant showing signs of acute bilirubin encephalopathy.\n\n**Follow-up**\n- Arrange close follow-up for all at-risk infants\n- Recheck bilirubin levels as clinically indicated based on initial risk category and response to treatment\n- For preterm infants of diabetic mothers, account for delayed enteral feedings and decreased bilirubin excretion when planning monitoring frequency"
      }
    ]
  },
  {
    "article_id": 131,
    "article_title": "Pediatric Otolaryngology",
    "sections": [
      {
        "title": "Clinical Management Approach",
        "content": "**Initial Assessment**\n\nBegin with a thorough history and physical examination of the head and neck region. With patience and proper equipment, most children can be examined completely in the primary care setting.\n\n**When to Refer to Pediatric Otolaryngology**\n\nReferral should be considered when:\n- A disorder fails to respond to initial therapy\n- A condition becomes chronic or recurrent\n- An unusual or complex problem is encountered\n- Specialized diagnostic testing (such as audiologic evaluation) is needed\n- Surgical intervention may be indicated\n\n**Communicating with Families About Referral**\n\nWhen referring a child to a pediatric otolaryngologist, explain to parents or caregivers:\n- The specific reason for referral\n- That evaluation will likely include ear examination and audiologic testing\n- That referral does not automatically mean surgery will be performed\n- That the otolaryngologist will explain management options, benefits, and risks\n- That many alternatives for management exist and surgical decisions are elective\n- That they should express any concerns to the surgeon\n\n**Special Considerations**\n\nA more aggressive diagnostic and management approach is recommended for:\n- Younger children\n- Children with underlying medical conditions (such as Down syndrome)\n- Children with cochlear implants\n- Children with craniofacial abnormalities"
      }
    ]
  },
  {
    "article_id": 132,
    "article_title": "Type 1 Diabetes Mellitus",
    "sections": [
      {
        "title": "Management",
        "content": "**Initial Assessment and Diagnosis**\n\nDiagnosis is confirmed using American Diabetes Association criteria:\n- Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L), OR\n- 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during 75-g oral glucose tolerance test, OR\n- Random plasma glucose ≥200 mg/dL (11.1 mmol/L) with classic hyperglycemia symptoms, OR\n- HbA1C ≥6.5%\n\nFasting or stimulated C-peptide is measured to assess remaining beta cell function. Autoantibodies (islet cell antibodies, anti-GAD, IA-2, insulin autoantibodies) are screened for to confirm autoimmune etiology.\n\n**Ongoing Management**\n\nAn intensive insulin regimen is implemented with the following components:\n\n1. **Insulin dosing and timing**: Children receiving fixed-dose insulin eat at consistent times coinciding with the peak action of the insulin preparation used. Insulin doses are adjusted based on food intake, physical activity, and blood glucose concentrations.\n\n2. **Flexible regimens**: Children using insulin pumps or basal-bolus regimens with long-acting basal insulin preparations (glargine, detemir) have flexibility in meal timing due to absence of significant peaks in basal insulins.\n\n3. **Dietary management**: A balanced diet with carbohydrate counting matched to insulin administration is provided.\n\n4. **Exercise**: Regular physical activity is encouraged as part of the management plan.\n\n5. **Blood glucose monitoring**: Essential monitoring is performed to maintain near-normal glycemia.\n\n6. **Target glycemic control**: HbA1c is maintained at <48 mmol/mol (6.5%) to reduce long-term complications.\n\n**Patient and Family Education**\n\nAdjustment of all diabetes regimen components (insulin, diet, exercise, monitoring) is taught. A united team approach with unambiguous guidelines is established. Progress is communicated promptly, and peer group support is used to promote adherence and health outcomes."
      }
    ]
  },
  {
    "article_id": 133,
    "article_title": "Acute Asthma Exacerbation",
    "sections": [
      {
        "title": "Management at the Bedside",
        "content": "**Immediate Assessment**\n\nSeverity is rapidly evaluated using clinical signs:\n- Accessory muscle use, limited ability to speak, upright posture preference\n- Paradoxical pulse >25 mm Hg\n- Heart rate >130 bpm, respiratory rate >25 breaths/min\n- Peak expiratory flow <50% predicted\n- Oxygen saturation <92%\n- Any sign of life-threatening exacerbation (silent chest, drowsiness, confusion)\n\n**If any severe or life-threatening signs are present, immediate transfer to the ED is required**\n\n---\n\n**First-Line Therapy**\n\n1. **Supplemental oxygen** — administered as first-line therapy to maintain adequate oxygenation; close monitoring for deterioration is essential\n\n2. **Short-acting beta-agonist (SABA)** — frequent bronchodilator treatments are given\n   - Home treatment: 2–4 puffs via metered dose inhaler, or 1–2 puffs SABA in combination treatment\n\n3. **Systemic corticosteroids** — a course of oral or intravenous corticosteroid is given\n   - IV corticosteroids are considered if the patient is unable to tolerate the oral route\n\n---\n\n**Additional Considerations**\n\n- **High-dose ipratropium bromide** — addition leads to decreased rate of hospitalization\n- **Intravenous magnesium** — considered in severe exacerbations\n- **Caution with SABA dosing**: increasing frequency and dosage increases pulmonary blood flow through obstructed, poorly oxygenated areas, worsening ventilation/perfusion mismatch and hypoxemia if airway obstruction is not resolved\n\n---\n\n**Follow-Up After ED or Hospitalization**\n\n- Outpatient follow-up within 1–2 days in children\n- Outpatient follow-up within 1 week in adolescents\n- A written [[107|asthma]] action plan is ensured to be in place before discharge"
      }
    ]
  },
  {
    "article_id": 134,
    "article_title": "Birth Asphyxia",
    "sections": [
      {
        "title": "Management at the Bedside",
        "content": "**Initial Assessment and Approach**\n\nWhen an infant does not breathe at birth, secondary apnea is assumed to be present and resuscitation is begun immediately. Primary and secondary apnea are not distinguished clinically.\n\n**Immediate Actions**\n\n1. **The infant's condition is assessed** using the Apgar score at 1 minute and 5 minutes after delivery, and at 5-minute intervals if the infant remains unwell. Heart rate, respiratory effort, muscle tone, reflex irritability, and colour are evaluated.\n\n2. **Tactile stimulation is provided** (drying, slapping the feet) as an initial measure; this may restart breathing in primary apnea but is not effective in secondary apnea.\n\n3. **Ventilatory support is initiated** without delay if the infant remains apnoeic or has inadequate respiratory effort after brief tactile stimulation. Ventilatory support must be provided within minutes to prevent death.\n\n**Ongoing Management**\n\nResuscitative efforts continue according to current American Heart Association and American Academy of Pediatrics guidelines. Heart rate, blood pressure, and oxygenation status are monitored. Signs of neonatal neurologic dysfunction (seizures, encephalopathy, abnormal tone) and multiple organ involvement (renal, pulmonary, hepatic, cardiac, gastrointestinal dysfunction) are assessed for.\n\nNote: The reference passages do not provide specific drug doses, ventilation parameters, or detailed resuscitation protocols. Current AHA-AAP resuscitation guidelines provide complete management algorithms."
      }
    ]
  },
  {
    "article_id": 135,
    "article_title": "Child Sexual Abuse",
    "sections": [
      {
        "title": "Clinical Evaluation and Management",
        "content": "**Initial Assessment**\n\nA complete history and physical examination are performed. A high index of suspicion is maintained based on nonverbal clues, psychosomatic symptoms, and presenting complaints such as vaginal itching or discharge.\n\n**Physical Examination Technique**\n\nA systematic examination is conducted, including:\n- Inspection of genital, perianal, and anal areas using appropriate terminology\n- Assessment for anal and perianal abnormalities\n- Evaluation for evidence of sexually transmitted infections\n- Identification of foreign bodies\n- Documentation of nongenital injuries\n- Careful distinction between normal anatomical variants and signs of abuse\n- Assessment for internal injury when indicated\n\n**Interview Process**\n\n- The child is interviewed separately from parents, using age-appropriate techniques\n- Repetition of questioning is minimized to reduce trauma\n- Drawings are used as communication aids if helpful\n- Parents are interviewed separately\n- All information is documented carefully\n\n**Documentation and Reporting**\n\n- A legal chain of evidence is maintained throughout evaluation\n- Precise, objective documentation with appropriate anatomical terminology is used\n- A mandatory report to Child Protective Services is made if reasonable suspicion of abuse exists\n- Reporting occurs regardless of whether abuse can be definitively proven\n- This obligation applies in all 50 states"
      }
    ]
  }
]